🔎 Trials Near Me

Home › Opioid Overdose › NCT04892251

Ketamine Assisted Psychotherapy for Opioid Use Disorder

RecruitingPhase 1/2

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Diagnosis of Opioid Use Disorder
2. Receiving OUD treatment with a buprenorphine formulation

Exclusion Criteria:

1. Previous experience with a mindfulness-based intervention program
2. Pregnancy
3. Any serious medical, mental, or cognitive issue that prevents successful participation in a mindfulness-based group treatment program
4. Prior use of ketamine other than as prescribed by a physician
5. Any of the following medical conditions

Blood Vessel Disease Heart Valve Disease Heart Failure Class 2 or Above Heart Disease Pregnancy/Breastfeeding Arteriovenous Malformation History of Intracranial Bleeding or Stroke History of Seizures Hypoxia defined by current need for supplemental oxygen Liver Disease History of allergic reaction to Ketamine Dementia (moderate-severe) History of Psychotic Disorder, Bipolar Disorder, or Personality Disorder Dissociative Identity Disorder

About the study

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

What is being tested

Sponsor: University of Utah · Participants: 60 · Started: May 20, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT04892251

Locations in the U.S.

UtahCenter on Mindfulness and Integrative Health Intervention Development, Salt Lake City

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.